RDY financial statements
The full income statement, balance sheet, and cash-flow statement for Dr. Reddy's Laboratories Ltd (RDY), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|---|
| Income Statement | as ofMar 31 ’26 | as ofMar 31 ’25 | as ofMar 31 ’24 | as ofMar 31 ’23 | as ofMar 31 ’22 | |
| Revenue | 3.80B-1.3% | 3.85B+14.1% | 3.37B+10.1% | 3.06B+6.4% | 2.88B+12.6% | |
| 2.00B-10.9% | 2.25B+13.9% | 1.98B+13.9% | 1.74B+13.5% | 1.53B+10.1% | ||
| Cost of revenue | 1.79B+12.4% | 1.60B+14.4% | 1.40B+5.2% | 1.33B-1.7% | 1.35B+15.6% | |
| Research & development | 272M-15.9% | 324M+17.1% | 276M+14.5% | 241M+2.8% | 235M+5.3% | |
| Operating income | 572M-32.7% | 849M+3.8% | 818M+15.0% | 712M+79.8% | 396M+21.0% | |
| Interest expense | 42.3M+26.4% | 33.4M+61.8% | 20.7M+16.2% | 17.8M+38.3% | 12.9M-1.6% | |
| Pre-tax income | 620M-31.7% | 907M+4.5% | 868M+15.5% | 752M+73.4% | 434M+21.9% | |
| Income tax | 140M-39.5% | 231M+18.1% | 195M+2.6% | 191M+62.6% | 117M-5.2% | |
| 480M-29.0% | 676M+0.6% | 673M+19.8% | 561M+77.4% | 316M+36.2% | ||
| Net income to common | 484M-27.5% | 668M-0.7% | 673M+19.8% | 561M | — | |
| $0.58-27.4% | $0.80-0.7% | $0.81+19.6% | $0.67+77.3% | $0.38+36.2% | ||
| EPS (basic) | $0.58-27.4% | $0.80-0.8% | $0.81+19.6% | $0.68+77.2% | $0.38+36.2% | |
| Weighted-avg shares (basic) | 832M-0.1% | 833M+0.1% | 832M+0.2% | 830M+0.1% | 829M+0.0% | |
| Weighted-avg shares (diluted) | 833M-0.1% | 834M+0.1% | 834M+0.2% | 832M+0.0% | 832M+0.0% | |
| Dividends per share | $0.09-4.3% | $0.09-2.2% | $0.10-74.1% | $0.37+456.5% | $0.07-0.4% | |
| Balance Sheet | as ofMar 31 ’26 | as ofMar 31 ’25 | as ofMar 31 ’24 | as ofMar 31 ’23 | as ofMar 31 ’22 | |
| 3.23B+10.5% | 2.93B-1.7% | 2.98B+19.7% | 2.49B+3.8% | 2.40B+18.2% | ||
| Cash & equivalents | 165M-4.0% | 171M+101.1% | 85.3M+21.2% | 70.4M-64.0% | 196M-3.5% | |
| Accounts receivable | 1.08B+2.4% | 1.06B+9.8% | 963M+9.2% | 882M+0.3% | 880M+29.6% | |
| Inventory | 820M-1.5% | 832M+9.1% | 763M+28.7% | 593M-11.6% | 670M+8.0% | |
| 6.20B+7.5% | 5.77B+24.1% | 4.65B+18.7% | 3.92B+1.6% | 3.86B+6.3% | ||
| Property, plant & equipment | 1.24B+8.5% | 1.14B+24.0% | 923M+14.0% | 809M-1.2% | 819M+4.9% | |
| Goodwill | 138M-0.1% | 138M+170.8% | 51.0M-1.3% | 51.7M-11.2% | 58.2M-6.8% | |
| Total non-current assets | 2.97B+4.5% | 2.84B+69.8% | 1.67B+16.9% | 1.43B-2.1% | 1.46B-8.8% | |
| 1.79B+17.6% | 1.53B+32.4% | 1.15B+10.3% | 1.05B-15.6% | 1.24B+8.6% | ||
| Short-term & current debt | 64.3M+541.0% | 10.0M-36.1% | 15.7M-73.2% | 58.5M+336.5% | 13.4M+13.4% | |
| 2.13B+16.8% | 1.82B+42.1% | 1.28B+16.0% | 1.11B-17.9% | 1.35B+6.6% | ||
| Long-term debt | 131M+42.0% | 92.0M+28.0% | 71.9M+361.9% | 15.6M-79.4% | 75.7M-12.1% | |
| 4.04B+3.5% | 3.90B+15.9% | 3.37B+19.7% | 2.81B+12.0% | 2.51B+6.1% | ||
| Total equity incl. non-controlling | 4.07B+3.3% | 3.95B+17.2% | 3.37B+19.7% | 2.81B+12.0% | 2.51B+6.1% | |
| Common shares outstanding | — | 833M+0.2% | 831M+0.1% | 830M+0.1% | 829M-0.0% | |
| Shares outstanding (cover) | 835M+0.0% | 834M+0.0% | 834M+0.2% | 833M+0.1% | 832M+0.1% | |
| Cash Flow | as ofMar 31 ’26 | as ofMar 31 ’25 | as ofMar 31 ’24 | as ofMar 31 ’23 | as ofMar 31 ’22 | |
| 642M+17.0% | 549M-0.0% | 549M-25.2% | 733M+94.3% | 377M-21.5% | ||
| Depreciation & amortization | 233M+15.6% | 202M+12.4% | 179M+13.9% | 157M-0.9% | 159M-7.9% | |
| Intangible amortization | 90.3M+16.6% | 77.4M+21.8% | 63.6M+27.0% | 50.1M+1.6% | 49.3M-14.3% | |
| Capital expenditure | — | 325M+64.0% | 198M+40.5% | 141M-28.4% | 197M+50.0% | |
| Free cash flow | — | 224M-36.2% | 351M-40.8% | 592M+228.0% | 181M-48.4% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt issued | 1.35B+42.2% | 953M+307.4% | 234M-61.8% | 613M-11.4% | 692M+6.4% | |
| Long-term debt repaid | 1.13B+69.7% | 664M+296.0% | 168M-80.4% | 854M+32.6% | 644M+15.5% | |
| Common stock issued | 0.00-100.0% | 83.4M | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00-100.0% | 16.4M | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 75.3M-4.4% | 78.7M-2.0% | 80.3M+29.5% | 62.0M+11.4% | 55.7M-0.4% | |
| Valuation Ratios | as ofMar 31 ’26 | as ofMar 31 ’25 | as ofMar 31 ’24 | as ofMar 31 ’23 | as ofMar 31 ’22 | |
| Market cap | 11.6B+5.0% | 11.0B-9.9% | 12.2B+28.8% | 9.48B+2.2% | 9.27B-9.2% | |
| P/E | 24.1×+48.0% | 16.3×-25.2% | 21.8×+28.8% | 16.9×-42.4% | 29.3×-33.3% | |
| P/S | 3.0×+6.4% | 2.9×-28.3% | 4.0×+28.8% | 3.1×-3.9% | 3.2×-19.3% | |
| P/B | 2.9×+1.5% | 2.8×-35.0% | 4.3×+28.8% | 3.4×-8.8% | 3.7×-14.4% | |
| P/FCF | 51.7×+5.0% | 49.2×+138.6% | 20.6×+28.8% | 16.0×-68.8% | 51.4×+76.0% | |
| Earnings yield | 4.2%-32.4% | 6.1%+33.8% | 4.6%-22.4% | 5.9%+73.5% | 3.4%+50.0% | |
| FCF yield | 1.9%-4.8% | 2.0%-58.1% | 4.8%-22.4% | 6.2%+220.9% | 1.9%-43.2% | |
| Dividend yield | 0.65%-8.9% | 0.72%+8.8% | 0.66%-79.9% | 3.3%+444.8% | 0.60%+9.8% | |
| Source filing | 20-F | 20-F | 20-F | 20-F | 20-F |
About this data
Source: RDY’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all RDY filings on SEC EDGAR → Not investment advice.